Prokarium hires Henry as COO

Prokarium Ltd. hired Dara Henry as COO, and announced FDA’s clearance of an IND for immunotherapy ZH9 to begin testing for non-muscle invasive bladder cancer. Henry was most recently an entrepreneur-in-residence at Evotec SE (Xetra:EVT; NASDAQ:EVO). Previously, he served as head of operations and business development at Achilles Therapeutics plc (NASDAQ:ACHL), and spent nine years at GSK plc (LSE:GSK; NYSE:GSK).

Actinium Pharmaceuticals Inc. (NYSE-A:ATNM), which is developing radiotherapies, hired Lynn Bodarky as CBO. Bodarky joins from HiFiBiO Inc. where she was SVP business development & alliance management...